DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2147506): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations) |
(Changed label, description and/or aliases in de, and other parts: Adding German translations) |
||||||||||||||
label / de | label / de | ||||||||||||||
ENTWICKLUNG EINER PLATTFORM FÜR MUTANOMA IDENTIFIKATION UND PERSONALISIERTE IMPFUNG BEI KREBSPATIENTEN – PRECIVAX | |||||||||||||||
Property / summary | |||||||||||||||
BIOTECHNOLOGIE (German) | |||||||||||||||
Property / summary: BIOTECHNOLOGIE (German) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: BIOTECHNOLOGIE (German) / qualifier | |||||||||||||||
point in time: 25 December 2021
|
Revision as of 11:49, 25 December 2021
Project Q2147506 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX |
Project Q2147506 in Italy |
Statements
132,201.83 Euro
0 references
178,156.84 Euro
0 references
74.21 percent
0 references
1 November 2016
0 references
31 December 2018
0 references
UNISALERNO- DIFARMA
0 references
BIOTECNOLOGIE (Italian)
0 references
BIOTECHNOLOGY (English)
0 references
Identifiers
B48I17000350008
0 references